Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results
- PMID: 8892473
- DOI: 10.1016/s0360-3016(96)00264-7
Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results
Abstract
Purpose: To minimize xerostomia in patients receiving bilateral head and neck irradiation (RT) by using conformal RT planning to spare a significant volume of one parotid gland from radiation.
Methods and materials: The study involved 15 patients with head and neck tumors in whom bilateral neck radiation was indicated. The major salivary glands and the targets (tumor, surgical bed, metastases to lymph nodes, and the locations of lymph nodes at risk for metastases) were outlined on axial computed tomography images. Beam's-eye view (BEV) displays were used to construct conformal beams that delivered the prescribed doses to the targets while sparing from direct radiation most of one parotid gland. The gland that was planned to be spared resided in the neck side that was judged in each patient to be at a lesser risk of metastatic disease. Major salivary gland flow rates and the responses to a subjective xerostomia questionnaire were assessed before, during, and after radiation.
Results: Radiation planning for patients with central oropharyngeal tumors required the generation of multiple axial nonopposed beams. The resulting isodoses encompassed the targets, including the retropharyngeal nodes and the jugular nodes up to the base of skull bilaterally, while limiting the dose to the oral cavity, spinal cord, and one parotid gland. For patients with lateralized tumors, the ipsilateral neck side was treated up to the base of the skull; in the contralateral neck side, the treatment included the subdigastric nodes but excluded the jugular nodes at the base of the skull and most of the parotid gland. This was accomplished by a moderate gantry angle that was chosen using the BEV displays. Three months following the completion of radiation, the spared parotid glands retained on average 50% of their unstimulated and stimulated flows. In contrast, no saliva flow was measured from the unspared glands in any of the patients. Subjective xerostomia was absent, mild, or not different from that reported before radiation in 10 of 15 patients (67%).
Conclusion: Partial parotid gland sparing is feasible by using three-dimensional planning in patients undergoing bilateral head and neck radiation. Approximately 50% of the saliva flow from the spared glands may be retained, and most patients thus treated have no or mild xerostomia in the early period after the completion of radiation. Whether tumor control and late complications are comparable to standard radiation will be assessed as more experience is gained.
Similar articles
-
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16. doi: 10.1016/s0360-3016(00)01441-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240231
-
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):695-704. doi: 10.1016/s0360-3016(01)01512-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395238
-
Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):559-68. doi: 10.1016/s0360-3016(98)00082-0. Int J Radiat Oncol Biol Phys. 1998. PMID: 9635702
-
Dose and volume impact on radiation-induced xerostomia.Rays. 2005 Apr-Jun;30(2):145-8. Rays. 2005. PMID: 16294907 Review.
-
Partial irradiation of the parotid gland.Semin Radiat Oncol. 2001 Jul;11(3):234-9. doi: 10.1053/srao.2001.23484. Semin Radiat Oncol. 2001. PMID: 11447580 Review.
Cited by
-
Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study.Radiat Oncol. 2013 Jan 31;8:26. doi: 10.1186/1748-717X-8-26. Radiat Oncol. 2013. PMID: 23369221 Free PMC article.
-
The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):660-9. doi: 10.1016/j.ijrobp.2006.09.021. Epub 2006 Dec 4. Int J Radiat Oncol Biol Phys. 2007. PMID: 17141973 Free PMC article.
-
Association between objective measures of oral health and salivary gland irradiation with patient-reported outcomes following head and neck radiation therapy.Head Neck. 2024 Dec;46(12):3066-3075. doi: 10.1002/hed.27884. Epub 2024 Jul 20. Head Neck. 2024. PMID: 39032116
-
Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):892-900. doi: 10.1016/j.ijrobp.2015.07.2283. Epub 2015 Jul 29. Int J Radiat Oncol Biol Phys. 2015. PMID: 26530759 Free PMC article.
-
Phase 2 results from Radiation Therapy Oncology Group Study 0537: a phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia.Cancer. 2012 Sep 1;118(17):4244-52. doi: 10.1002/cncr.27382. Epub 2012 Jan 17. Cancer. 2012. PMID: 22252927 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical